Erythromycin Delayed-Release Tablets
DEFINITION
Erythromycin Delayed-Release Tablets contain NLT 90.0% and NMT 120.0% of the labeled amount of erythromycin (C37H67NO13).
USP REFERENCE STANDARDS FOR PURCHASE
USP Erythromycin B RSUSP Erythromycin C RS
USP Erythromycin RS
USP Erythromycin Related Compound N RS
